grant

The role of the epicardium and IRE1 in mediating environmental exposure on cardiac function

Organization MICHIGAN STATE UNIVERSITYLocation EAST LANSING, UNITED STATESPosted 27 Sept 2025Deadline 31 Aug 2027
NIHUS FederalResearch GrantFY20253-D3-Dimensional3DAffectAnimalsArrhythmiaAutomobile DrivingBlood PlasmaBlood SerumBody TissuesCancersCardiacCardiac ArrhythmiaCardiac DiseasesCardiac DisordersCardiac Muscle CellsCardiac MyocytesCardiocyteCardiovascular DiseasesCause of DeathCell BodyCell Communication and SignalingCell Culture TechniquesCell DeathCell SignalingCellsChemicalsChiro-InositolCholesterolChronicCommunicationDevelopmentDiabetes MellitusDiseaseDisease ProgressionDisorderDrugsDyslipidemiasER stressEarly identificationEcological impactEndogenous FactorsEnvironmentEnvironmental ExposureEnvironmental FactorEnvironmental ImpactEnvironmental PollutantsEnvironmental Risk FactorEnzyme GeneEnzymesEpicardiumExogenous FactorsExposure toFatty AcidsFoodFood ChainFree Fatty AcidsGenerationsGoalsHeartHeart ArrhythmiasHeart DiseasesHeart HypertrophyHeart Muscle CellsHeart failureHeart myocyteHouseholdHumanHypertensionIn VitroInositolIntermediary MetabolismIntracellular Communication and SignalingInvestigationLinkLipidsLipoproteinsMalignant NeoplasmsMalignant TumorMeasuresMediatingMedicationMesoinositolMetabolic ProcessesMetabolismModern ManMyocardial depressionMyocardial dysfunctionMyocardiumNonesterified Fatty AcidsOrganOrganismOrganoidsPFASPharmaceutical PreparationsPhenotypePhysiologyPlasmaPlasma SerumPlayPoly-fluoroalkyl substancesProcessProteinsRespiratory DiseaseRespiratory System DiseaseRespiratory System DisorderReticuloendothelial System, Serum, PlasmaRoleRouteSaturated Fatty AcidsSerumSignal TransductionSignal Transduction PathwaySignal Transduction SystemsSignalingStructureTestingTissuesVascular Hypertensive DiseaseVascular Hypertensive Disorderbiological signal transductionblood lipidcardiac dysfunctioncardiac failurecardiac functioncardiac hypertrophycardiac musclecardiomyocytecardiovascular disease riskcardiovascular disordercardiovascular disorder riskcell culturecell culturesdesigndesigningdevelopmentaldiabetesdiabetic cardiomyopathydiabetic cardiopathydiabetic cardiopathy diseasediabetic cardiopathy disorderdiabetic cardiovascular diseasediabetic cardiovascular disorderdrinking waterdrivingdrug/agentearly biomarkersearly detection biomarkersearly detection markersendoplasmic reticulum stressenvironmental contaminantenvironmental riskexposed human populationfat metabolismfunction of the heartheart disorderheart dysfunctionheart functionheart musclehiPSChigh blood pressurehuman exposurehuman iPShuman iPSChuman induced pluripotent cellhuman induced pluripotent stem cellshuman inducible pluripotent stem cellshuman inducible stem cellshyperpiesiahyperpiesishypertensive diseasehypertensive disorderinduced human pluripotent stem cellsinsightischemic cardiomyopathyknock-downknockdownlipid metabolismliving systemlong chain fatty acidmalignancymanufacturing facilitymanufacturing plantsnecrocytosisneoplasm/cancernew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypackaging materialperfluorinated alkyl substancesperfluoro octane sulfonateperfluoro-octane sulfonic acidperfluoroalkyl substancesperfluoroalkylated substancesperfluorooctane sulfonateperfluorooctane sulfonic acidperfluorooctanesulfonateperfluorooctanesulfonic acidperfluorooctanoateperfluorooctanoic acidpolyfluorinated alkyl substancespolyfluoroalkyl substancesproduction plantsresponsesensorsocial rolestem cell technologythree dimensionalwasting
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Advances in cell culture techniques and stem cell technology have enabled generation of 3-
dimensional organoids capable of recapitulating the structure and physiology of human organs

better than 2D cultures. These organoids can aid in identifying early biomarkers of diseases, and

understanding the impact of environmental factors on the initiation and progression of diseases.

We recently used our human heart organoids (hHOs) derived from human induced pluripotent

stem cells (iPSCs) to explore changes in lipid profile mediated by endoplasmic reticulum (ER)

stress sensor proteins.

Exogenous chemicals (e.g., per-and polyfluoroalkyl substances (PFAS), drugs, etc.) and

endogenous metabolites (e.g., cholesterol and saturated fatty acids (SFAs)) negatively affect

cardiac function. PFAS are found in many household cleaning products and commercial

packaging materials. Once released to the environment, these “forever chemicals” degrade

slowly, resulting in detectable levels in drinking water, food, and animals, including humans. PFAS

are ubiquitous environmental contaminants that also accumulate in the food chain, which is one

of the main routes of human exposure. Evidence have linked PFAS to altered lipid profile and

cardiovascular disease (CVD). We and others have found that PFAS induces ER stress, notably

inositol-requiring enzyme 1α (IRE1α) signaling. ER stress and activation of IRE1α is involved in

various conditions that advance heart diseases. Thus far, studies on the changes in lipid

composition induced by PFAS has been limited to cholesterol, lipoproteins and TG. We found that

(i) IRE1α mediates changes in the lipid profile (notably, long-chain fatty acids) in our hHOs, and

(ii) PFAS activates IRE1α signaling and is linked to dyslipidemia and CVD risk. Therefore, we

hypothesize that PFAS activation of IRE1α signaling alters the lipid profiles and negatively affects

cardiac function. We further propose that our organoids, which contain epicardial cells (that

provide trophic factors and can mediate lipid metabolism) in addition to cardiomyocytes, enable

investigation of the influence of epicardial cells on the cardiac lipid profile and function. In the first

aim, we will investigate the changes in lipid content (i.e., very long chain long chain fatty acids:

odd and even) and cardiac function induced by PFAS exposure and mediated by IRE1α. In the

second aim, we will investigate the PFAS-induced changes in lipid profile and cardiac function

mediated by the epicardium.

Grant Number: 1R21ES037451-01
NIH Institute/Center: NIH

Principal Investigator: CHRISTINA CHAN

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →